Q2 FY27 Growth: Revenue at INR 2,829 Cr, 19% YoY growth

ASTERDM Top-line and profit growth: 19% revenue and 25% operating EBITDA growth show demand recovery and operating leverage in the quarter. Margin expansion (111 bps) driven by mature-unit mix and favourable payor mix—indicates improving unit economics, not just volume lift. Occupancy and volumes: patient volumes +12% and occupancy +335 bps to 68% improve fixed-cost absorption and revenue per bed. Cash flow improving: cash from operating activity rose to INR 656 Cr (last period INR 425 Cr, +54%), supporting organic capex and debt servicing. Leverage manageable: gross debt ~INR 3,959 Cr with net debt/EBITDA (pre IND AS) ~0.87 as of Sep 30, 2026—gives room to fund expansion without immediate refinancing pressure.